Back to Research Home
DGXQuest Diagnostics Incorporated
Health Care · Health Care Services · Large
$241.89−0.57%
As of 23 Oct 2026Mkt cap $26.6B
Stage 13
WAIT
Fundamentals
47.0/75
Technical
5.6/15
Independent
52.6/90
GCAE viewelevated earnings event risk blocks an independent BUY decision
Price
- 1M
- +2.2%
- 3M
- +4.3%
- 6M
- +23.2%
- 1Y
- +33.5%
Financials & valuation
Cached filing evidence · as of 2026-10-23
Valuation
- P/E
- 24.0xHist median 22.0x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 19.9x
- FCF yield
- 5.0%
Quality
- ROIC
- 9.0%
- Operating margin
- 13.6%
- FCF margin
- 12.3%
- Current ratio
- 1.0x
Growth
- Revenue growth
- +11.8%Latest FY YoY
- Revenue CAGR
- +0.6%
- EPS CAGR
- −13.4%
- FCF CAGR
- −7.2%
Capital
- Share-count trend
- 0.0%3Y annualised
- Net debt
- $6.0B3.2x OCF
Annual trend
- CAGR 2021–2025
- +0.6%
- Latest · 2025
- $11B
- YoY
- +11.8%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
elevated earnings event risk blocks an independent BUY decision
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2027-02-09
More details & evidence
Production decision
- Stage 13
- WAIT
- Technical state
- extended
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-23
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded